Get Mystery Box with random crypto!

Ayush-64 Clinical trials conducted by the Central Council f | UPSC PIB NEWS

Ayush-64

Clinical trials conducted by the Central Council for Research in Ayurvedic Sciences (CCRAS) has shown that the polyherbal drug Ayush-64 has notable antiviral, immune-modulator and antipyretic properties.

What’s in the News?

◆ The clinical trials were conducted by CCRAS in collaboration with the Council of Scientific and Industrial Research (CSIR) and many other research organizations and medical colleges across the country.

◆ The trials have shown that Ayush-64 is found to be useful in the treatment of asymptomatic, mild and moderate COVID-19 infection.

◆ Consequently, the drug is now repurposed for COVID-19.

What is Ayush-64?                              

◆ Ayush-64 is an Ayurvedic formulation developed by CCRAS.

Originally developed in 1980 for the management of Malaria, this drug has now been repurposed for Covid-19 as its ingredients showed notable antiviral, immune-modulator and antipyretic properties.

◆ The in-silico study done on Ayush 64 showed that 35 out of 36 of its Phyto-constituents have high binding affinity against the COVID-19 virus.

◆ The formulation has also shown very promising results in Influenza like illnesses.

◆ With scientific evidence generated from six clinical studies across India, Ayush 64 has been identified as a potential adjunct to standard care in the management of asymptomatic, mild and moderate COVID-19 to improve the clinical recovery and quality of life.

◆ Ayush-64 is found to significantly enhance the speed of clinical recovery in terms of disease symptoms and severity. It also has significant beneficial effects on general health, fatigue, anxiety, stress, appetite, general wellbeing and sleep.

◆ The formulation can be taken by patients at any stage of the COVID-19 disease. However, its efficacy was scientifically studied in asymptomatic, mild and moderate disease without risk factors for poor outcome and those not requiring emergency interventions or hospitalization are eligible to take Ayush-64.

About Central Council for Research in Ayurvedic Sciences (CCRAS):

◆ It is an autonomous body of the Ministry of AYUSH.

◆ It is an apex body in India for the formulation, coordination, development and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa system of medicine.

◆ The activities are carried out through its 30 Institutes/Centres/Units located all over India and also through collaborative studies with various Universities, Hospitals and Institutes.

◆ The research activities of the Council include Medicinal Plant Research (Medico-Ethno Botanical Survey, Pharmacognosy and Tissue Culture), Drug Standardization, Pharmacological Research, Clinical Research, Literary Research & Documentation and Tribal Health Care Research Programme.

◆ It is headquartered in New Delhi.



#GS3


JOIN-- @UPSC_PIB_NEWS